查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922436

日本重组蛋白市场报告：按产品、应用、最终用户和地区划分（2026-2034年）

Japan Recombinant Protein Market Report by Product, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本重组蛋白市场规模达2.894亿美元。 IMARC集团预测，到2034年，该市场规模将达到6.007亿美元，2026年至2034年的复合年增长率（CAGR）为8.46%。推动市场成长的主要因素是生物製药（如单株抗体、疫苗和治疗性蛋白质）的不断发展，这些产品越来越多地被用于治疗包括癌症、自体免疫疾病和感染疾病的各种疾病。

重组蛋白是一种人工工程蛋白，它是透过将来自不同来源的遗传物质（通常是能够产生特定蛋白质的生物体的DNA）与宿主生物体的细胞蛋白质合成机制结合而产生的。这个过程在生物技术和製药行业至关重要，它能够大规模生产用于各种应用的特定蛋白质。为了建构重组蛋白，科学家将所需的基因序列导入宿主生物体，例如细菌、酵母或哺乳动物细胞。一旦宿主生物体吸收了外源DNA，它就会根据插入的遗传讯息开始合成目标蛋白。重组蛋白的应用十分广泛，包括治疗药物（例如胰岛素和疫苗）、研究工具（例如酵素和抗体）以及用于各种製程（例如生质燃料生产和食品加工）的工业酵素。它们的生产具有精确控制、扩充性和高纯度等优点，使其成为医学、科学和工业进步的关键。

日本重组蛋白市场趋势：

推动日本重组蛋白市场发展的因素很多。首先，癌症、糖尿病和自体免疫疾病等慢性病的日益增多，推动了对采用重组DNA技术生产的治疗性蛋白质的需求。因此，製药公司正大力投资新型生物製药的研发，进而促进了市场成长。此外，基因工程和生物技术的进步也改进了重组蛋白的生产过程。细胞株和酵母细胞株等表达系统的改进，使得复杂蛋白的生产产量和品质均有所提高，从而推动了市场扩张。同时，蛋白质体学和基因体学领域研发活动的蓬勃发展，也推动了作为研究工具的重组蛋白的需求。这些蛋白质对于研究基因功能、阐明蛋白质-蛋白质相互作用以及药物发现至关重要，进一步促进了市场成长。此外，个人化医疗的引入以及双特异性抗体和融合蛋白的开发，为治疗性蛋白质产业带来了新的机会，预计这些因素将在预测期内推动日本重组蛋白市场的发展。

本报告解答的关键问题：

  • 迄今为止，日本重组蛋白市场的发展趋势是什么？您预计未来几年该市场的发展趋势会如何？
  • 新冠疫情对日本重组蛋白市场产生了哪些影响？
  • 日本重组蛋白市场依产品分類的组成是怎样的？
  • 日本重组蛋白市场依应用领域分類的组成是怎样的？
  • 日本重组蛋白市场依最终用户分類的市场组成为何？
  • 请介绍日本重组蛋白市场价值链的各个环节。
  • 日本重组蛋白市场的主要驱动因素和挑战是什么？
  • 日本重组蛋白市场的结构是怎么样的？主要参与者有哪些？
  • 日本重组蛋白市场竞争有多激烈？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章 日本重组蛋白市场－引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本重组蛋白市场概述

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本重组蛋白市场－依产品细分

  • 抗体
  • 荷尔蒙
  • 生长因子
  • 细胞激素
  • 其他的

第七章 日本重组蛋白市场－依应用领域细分

  • 药物发现与开发
  • 学术研究
  • 生物技术调查
  • 生物製药生产
  • 其他的

第八章 日本重组蛋白市场－依最终用户细分

  • 製药和生物製药公司
  • 生技公司
  • 学术研究机构
  • CRO（受託研究机构）
  • 其他的

第九章 日本重组蛋白市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本重组蛋白市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章 日本重组蛋白市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A19281

Japan recombinant protein market size reached USD 289.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 600.7 Million by 2034, exhibiting a growth rate (CAGR) of 8.46% during 2026-2034. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others

Application Insights:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others

End User Insights:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan recombinant protein market?
  • What is the breakup of the Japan recombinant protein market on the basis of product?
  • What is the breakup of the Japan recombinant protein market on the basis of application?
  • What is the breakup of the Japan recombinant protein market on the basis of end user?
  • What are the various stages in the value chain of the Japan recombinant protein market?
  • What are the key driving factors and challenges in the Japan recombinant protein?
  • What is the structure of the Japan recombinant protein market and who are the key players?
  • What is the degree of competition in the Japan recombinant protein market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Recombinant Protein Market - Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Hormones
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Growth Factors
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Cytokines
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan Recombinant Protein Market - Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Academic Research
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Biotechnology Research
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Biopharmaceutical Production
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2020-2025)
    • 7.5.2 Market Forecast (2026-2034)

8 Japan Recombinant Protein Market - Breakup by End User

  • 8.1 Pharmaceutical and Biopharmaceutical Companies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Biotechnology Companies
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Academic and Research Institutes
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Contract Research Organization
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Recombinant Protein Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Recombinant Protein Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Recombinant Protein Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix